Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Uni-Bio Science Group Ltd. ( (HK:0690) ) has issued an announcement.
Uni-Bio Science Group Limited has disclosed a change in the internal shareholding structure within the family of chairman and executive director Kingsley Leung, triggered by a family arrangement involving several controlled entities and a family trust. Despite transfers among MJKPC Holdings, Lord Profit Limited, Automatic Result Limited and Skill Hand Limited, the Leung family’s aggregate holding remains at 1,790,391,464 shares, or about 29.98% of issued shares.
The company emphasized that all these shares remain under the same immediate family sphere of control and that the transactions will not affect the public float or create market impact. The family trust structure is expected to be terminated after a planned further transfer of 209,420,000 shares to Skill Hand Limited, while Kingsley Leung will stay on as chairman and executive director, and no changes to the board composition are anticipated.
The most recent analyst rating on (HK:0690) stock is a Hold with a HK$0.13 price target. To see the full list of analyst forecasts on Uni-Bio Science Group Ltd. stock, see the HK:0690 Stock Forecast page.
More about Uni-Bio Science Group Ltd.
Uni-Bio Science Group Limited is a Hong Kong-listed company incorporated in the Cayman Islands and traded under stock code 0690. The group operates in the biopharmaceutical sector, focusing on the research, development and commercialization of healthcare products, with governance led by a board comprising executive, non-executive and independent non-executive directors.
Average Trading Volume: 5,686,233
Technical Sentiment Signal: Sell
Current Market Cap: HK$577.8M
See more data about 0690 stock on TipRanks’ Stock Analysis page.